Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luisa Ronzoni

Showing results (41-50 of 45) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 45 results.
Clinical and Molecular Hepatology|June 2, 2025
Genome-wide interaction study with body mass index identifies CYP7A1 and GIPR as genetic modulators of metabolic dysfunction-associated steatotic liver diseaseOveis Jamialahmadi, Endrina Mujica, Lowri Morris, et al.
Genomics, Proteomics & Bioinformatics|May 4, 2026
Calling for Diversity: Improving Transfusion Safety Through High-Throughput Blood Group Microarray GenotypingMichael Wittig, Tim Alexander Steiert, Hesham ElAbd, et al.
European Journal of Human Genetics : EJHG|November 19, 2015
Preferences for prenatal tests for Down syndrome: an international comparison of the views of pregnant women and health professionalsMelissa Hill, Jo-Ann Johnson, Sylvie Langlois, et al.
The Journal of Clinical Investigation|February 10, 2026
Carriage of rare APOB variants predisposes to severe steatotic liver disease and hepatocellular carcinomaMatteo Mureddu, Serena Pelusi, Oveis Jamialahmadi, et al.
HGG Advances|June 30, 2024
Stratified analyses refine association between TLR7 rare variants and severe COVID-19Jannik Boos, Caspar I van der Made, Gayatri Ramakrishnan, et al.
Pageof 5

Showing results (41-50 of 45) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 45 results.
Clinical and Molecular Hepatology|June 2, 2025
Genome-wide interaction study with body mass index identifies CYP7A1 and GIPR as genetic modulators of metabolic dysfunction-associated steatotic liver diseaseOveis Jamialahmadi, Endrina Mujica, Lowri Morris, et al.
Genomics, Proteomics & Bioinformatics|May 4, 2026
Calling for Diversity: Improving Transfusion Safety Through High-Throughput Blood Group Microarray GenotypingMichael Wittig, Tim Alexander Steiert, Hesham ElAbd, et al.
European Journal of Human Genetics : EJHG|November 19, 2015
Preferences for prenatal tests for Down syndrome: an international comparison of the views of pregnant women and health professionalsMelissa Hill, Jo-Ann Johnson, Sylvie Langlois, et al.
The Journal of Clinical Investigation|February 10, 2026
Carriage of rare APOB variants predisposes to severe steatotic liver disease and hepatocellular carcinomaMatteo Mureddu, Serena Pelusi, Oveis Jamialahmadi, et al.
HGG Advances|June 30, 2024
Stratified analyses refine association between TLR7 rare variants and severe COVID-19Jannik Boos, Caspar I van der Made, Gayatri Ramakrishnan, et al.
Pageof 5